1. Copper-related genes predict prognosis and characteristics of breast cancer
   Yi Liu et al, 2023, Frontiers in Immunology CrossRef
2. The 3D in vivo chorioallantoic membrane model and its role in breast cancer research
   Cynthia Kohl et al, 2022, Journal of Cancer Research and Clinical Oncology CrossRef
3. HER2 Kinase-Targeted Breast Cancer Therapy: Design, Synthesis, and In Vitro and In Vivo Evaluation of Novel Lapatinib Congeners as Selective and Potent HER2 Inhibitors with Favorable Metabolic Stability
   Tamer A. Elwaie et al, 2020, Journal of Medicinal Chemistry CrossRef
4. The essential role of YAP in ERα36-mediated proliferation and the epithelial-mesenchymal transition in MCF-7 breast cancer cells
   Miso Park et al, 2022, Frontiers in Pharmacology CrossRef
5. Phase I/II trial of ruxolitinib in combination with trastuzumab in metastatic HER2 positive breast cancer
   Matthew Kearney et al, 2021, Breast Cancer Research and Treatment CrossRef
6. Combined treatment with ruxolitinib and MK-2206 inhibits the JAK2/STAT5 and PI3K/AKT pathways via apoptosis in MDA-MB-231 breast cancer cell line
   Esin Guvenir Celik et al, 2023, Molecular Biology Reports CrossRef
7. Natural compounds as a potential modifier of stem cells renewal: Comparative analysis
   Amaresh Mishra et al, 2023, European Journal of Pharmacology CrossRef
8. Design, synthesis, and antitumor screening of new thiazole, thiazolopyrimidine, and thiazolotriazine derivatives as potent inhibitors of VEGFR‐2
   Alaa A. Abd Elhameed et al, 2023, Drug Development Research CrossRef
9. A biofabricated vascularized skin model of atopic dermatitis for preclinical studies
   Xue Liu et al, 2020, Biofabrication CrossRef